Izotropic (IZOZF) Price & Analysis

Compare

15 Followers

IZOZF Stock Chart & Stats

$0.21

$0.01(17.44%)

At close: Jan 08 4:00 PM EST

$0.21

$0.01(17.44%)

Day’s Range― - ―

52-Week Range$0.12 - $0.37

Previous CloseN/A

Volume17.00K

Average Volume (3M)62.09K

Market Cap

$10.97M

Enterprise Value$17.65M

Total Cash (Recent Filing)$229.86K

Total Debt (Recent Filing)$2.97M

Price to Earnings (P/E)―

Beta-0.81

Next Earnings

Mar 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding67,784,676

10 Day Avg. Volume31,629

30 Day Avg. Volume62,088

Financial Highlights & Ratios

PEG Ratio-0.05

Price to Book (P/B)-2.90

Price to Sales (P/S)0.00

P/FCF Ratio-22.10

Enterprise Value/Market Cap1.61

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-460.75

Enterprise Value/Ebitda-7.27

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Focused Niche Product: Breast CT ImagingA dedicated breast CT platform targets a defined clinical niche (screening and diagnostic breast imaging). Specialization can create durable market positioning and higher technical barriers to entry versus general imaging, supporting steady adoption among focused customers over months.

Improving Cash Burn TrendAn improving burn rate signals management progress in cost control and operational efficiency. Even with negative cash flow, a sustained reduction in cash burn over successive periods meaningfully lowers near-term financing pressure and improves runway durability over the next several months.

Progress In Reducing Annual Net LossesYear-over-year improvement in net losses (relative to earlier periods) points to operational progress or controlled R&D/SG&A spending. If management sustains this trajectory, it supports a clearer path toward narrower losses or eventual break-even over a multi-quarter horizon.

Bears Say

No Revenue Reported (TTM)Absence of reported revenue indicates the commercial product is not yet generating sales, exposing the company to long-term viability risk. Without commercial cash inflows, the company depends on financing to fund operations, which creates execution and dilution risk over coming months.

Negative Equity And Limited AssetsNegative equity and a small asset base materially elevate solvency and refinancing risk. Over a multi-month horizon this structural weakness constrains strategic flexibility, increases cost of capital, and makes it harder to absorb setbacks or support scale-up without external funding.

Persistent Negative Operating And Free Cash FlowSustained negative operating and free cash flow means the business cannot self-fund development or commercialization. Continued external funding dependence raises execution risk, potential dilution, and the possibility of disrupted timelines if financing conditions tighten in the medium term.

Izotropic News

Izotropic Africa Pursues Moroccan Partnership to Advance Breast CT Expansion

The latest update is out from Izotropic ( ($TSE:IZO) ). Izotropic’s newly formed Casablanca-based venture, Izotropic Africa, is...

12d ago

Izotropic Moves to Establish African and GCC Hub for Breast CT Imaging

Izotropic ( ($TSE:IZO) ) has issued an update. Izotropic Corporation has signed a letter agreement with a business...

19d ago

Izotropic Raises Working Capital and Settles Debt with Equity Units

Izotropic ( ($TSE:IZO) ) has issued an update. Izotropic closed a $300,000 non-brokered private placement by issuing 1.2 million...

1M ago

Izotropic Plans $300,000 Private Placement to Advance IzoView Breast CT Commercialization

Izotropic ( ($TSE:IZO) ) has shared an announcement. Izotropic Corporation has provided a corporate update outlining its strategic...

1M ago

Izotropic Shareholders Approve All AGM Resolutions and Lower Quorum Threshold

Izotropic ( ($TSE:IZO) ) has provided an announcement. Izotropic Corporation reported that all resolutions presented at its Annual...

2M ago

Izotropic Corporation Announces Debt Settlement Agreement

Izotropic ( ($TSE:IZO) ) has shared an update. Izotropic Corporation has entered into a debt settlement agreement to...

3M ago

Izotropic Corporation Announces Debt Settlement Agreement

The latest announcement is out from Izotropic ( ($TSE:IZO) ). Izotropic Corporation has entered into a debt settlement...

3M ago

Izotropic Expands AI Integration in Breast Imaging with New Podcast Episode

The latest announcement is out from Izotropic ( ($TSE:IZO) ). Izotropic Corporation has released the second episode of...

4M ago

Izotropic Enhances Educational Outreach with New ‘Breast Imaging News’ Page

The latest announcement is out from Izotropic ( ($TSE:IZO) ). Izotropic Corporation has launched a ‘Breast Imaging News’...

4M ago

Izotropic Unveils Strategic Plans for IzoView Breast CT Platform

Izotropic ( ($TSE:IZO) ) has issued an announcement. Izotropic Corporation has released a video interview with CEO Bob...

5M ago

IZOZF FAQ

What was Izotropic Corp.’s price range in the past 12 months?

Izotropic Corp. lowest stock price was $0.12 and its highest was $0.37 in the past 12 months.

What is Izotropic Corp.’s market cap?

Izotropic Corp.’s market cap is $10.97M.

When is Izotropic Corp.’s upcoming earnings report date?

Izotropic Corp.’s upcoming earnings report date is Mar 26, 2026 which is in 17 days.

How were Izotropic Corp.’s earnings last quarter?

Izotropic Corp. released its earnings results on Dec 30, 2025. The company reported -$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.009.

Is Izotropic Corp. overvalued?

According to Wall Street analysts Izotropic Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Izotropic Corp. pay dividends?

Izotropic Corp. does not currently pay dividends.

What is Izotropic Corp.’s EPS estimate?

Izotropic Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Izotropic Corp. have?

Izotropic Corp. has 67,784,676 shares outstanding.

What happened to Izotropic Corp.’s price movement after its last earnings report?

Izotropic Corp. reported an EPS of -$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.976%.

Which hedge fund is a major shareholder of Izotropic Corp.?

Currently, no hedge funds are holding shares in IZOZF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Izotropic Corp.

Izotropic Corporation, a MedTech company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and 3D CT breast imaging platform for the earlier detection and diagnosis of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.